Ana Claudia Maretti Garcia, PhD

Dr. Maretti-Garcia’s research focuses on uncovering how the immune system contributes to the progression of chronic liver diseases. She specializes in advanced transcriptomic and real-time cellular behavior assays, leveraging these technologies to investigate the molecular and cellular mechanisms underlying liver dysfunction. Dr. Maretti-Garcia has developed an innovative in vitro framework for studying MASLD by integrating 3D human liver spheroids and multi-omic technologies. Using this approach, she aims to investigate how environmental pollutants, like PFAS, influence the progression of MASLD and hepatocellular carcinoma (HCC). Dr. Maretti-Garcia is also interested in the role of dietary factors in the onset of MASLD and in identifying new strategies for disease prevention and treatment.

• USC: USC Dean’s Pilot Award, 2024
• AASLD: Presidential Poster of Distinction, 2023
• USC: USC President Sustainability Initiative Award, 2023
• USC: RCLD Young Investigator Award, 2017
   – 2018
• AASLD: Basic Science Young Investigator Travel Award, 2016
• AASLD: Presidential Poster of Distinction, 2016
• Brazilian Society of Protozoology: Best Scientific Presentation Award, 2007

• Universidade Federal do Rio de Janeiro, Brazil — BS — 2004 — Biomedical Sciences
• FIOCRUZ, Brazil — MS — 2006 — Parasitology
• FIOCRUZ, Brazil — PhD — 2011 — Molecular and Cellular Biology
• University of California, Los Angeles, Los Angeles — 2013 — Post-doctoral, Immunology
• Cedars-Sinai, Los Angeles — 2014 — Post-doctoral, Molecular Immunology
• University of Southern California, Los Angeles — 2018 — Post-doctoral, Liver Biology
• University of Southern California, Los Angeles — 2021 — Post-doctoral, Liver Immunology

• Non-alcoholic Steatohepatitis
• Hepatitis C
• Autoimmune Hepatitis
• Immunology
• Molecular Biology
• PFAS

• Chatzi, Vaia
• Goodrich, Jesse
• DeLeve, Laurie
• Terrault, Norah
• Tsukamoto, Hidekazu
• Aung, Max